Opella Healthcare Switzerland AG
Opella Healthcare Switzerland AG is a OTC and phyto company based in Rotkreuz (Zug) recorded by Swissmedic as the authorisation holder for 22 human medicines. That places it 87 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | OTC and phyto |
|---|---|
| City | Rotkreuz |
| Canton | Zug |
| Authorisation holder | Yes |
| Medicines | 22 |
| Founded | Not available |
| Employees | 51-200 |
| Parent group | Opella Healthcare Group |
| Activity | Not available |
| Website | opellahealthcare.com |
Medicines authorised in Switzerland
Opella Healthcare Switzerland AG is recorded by Swissmedic as the authorisation holder for 22 human medicines. The table shows 22 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
22 of 22 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Bioflorin | 40506 | D | A07FA01 | 1979-01-15 |
| Bisolvon Ambroxol 1x TÄGLICH | 61245 | D | R05CB06 | 2010-05-06 |
| Bisolvon Dextromethorphan | 61441 | B | R05DA09 | 2011-06-08 |
| Bisolvon Hustensirup | 54619 | D | R05CB02 | 1998-04-27 |
| Bisolvon Kids Hustensirup | 68163 | D | R05CB02 | 2021-05-04 |
| Bisolvon Pentoxyverin 2.13 mg/ml | 69779 | D | R05DB05 | 2025-08-21 |
| Buscopan | 17353 | D | A03BB01 | 1952-06-14 |
| Buscopan | 17354 | D | A03BB01 | 1952-06-14 |
| Buscopan Inject | 17352 | B | A03BB01 | 1952-06-14 |
| Dulcolax Bisacodyl | 23390 | D | A06AB02 | 1957-05-14 |
| Dulcolax Bisacodyl | 23391 | D | A06AB02 | 1957-05-14 |
| Dulcolax Picosulfat | 56893 | D | A06AB08 | 2005-06-06 |
| Dulcolax Picosulfat | 57507 | D | A06AB08 | 2006-01-23 |
| Laxoberon | 37871 | B/D | A06AB08 | 1973-07-02 |
| Novalgin | 16950 | B | N02BB02 | 1952-03-24 |
| Novalgin | 16951 | B | N02BB02 | 1952-03-24 |
| Novalgin | 16952 | B | N02BB02 | 1952-03-24 |
| Pharmaton Kiddi Vita | 56687 | D | - | 2004-08-18 |
| Pharmaton Vital | 54967 | D | A11AB | 1999-08-25 |
| Pharmatovit Ginseng | 53682 | D | - | 1996-09-16 |
| Telfast 120 | 54204 | D | R06AX26 | 1997-06-26 |
| Telfastin 120 | 61283 | D | R06AX26 | 2010-06-29 |
Frequently asked questions
How many medicines does Opella Healthcare Switzerland AG have authorised in Switzerland?
Opella Healthcare Switzerland AG is recorded by Swissmedic as the authorisation holder for 22 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Opella Healthcare Switzerland AG based?
The Swiss location recorded for Opella Healthcare Switzerland AG is Rotkreuz, Zug.
Is Opella Healthcare Switzerland AG a Swissmedic authorisation holder?
Yes. Opella Healthcare Switzerland AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.